Sharon L Wardlaw1, Charles F Burant, Samuel Klein, Kana Meece, Anne White, Tom Kasten, Brendan P Lucey, Randall J Bateman. 1. Department of Medicine (S.L.W., K.M.), Columbia University College of Physicians & Surgeons, New York, New York 10032; Department of Internal Medicine (C.F.B.), University of Michigan Medical School, Ann Arbor, Michigan 48019; Center for Human Nutrition and Atkins Center for Excellence in Obesity Medicine (S.K.), Washington University School of Medicine, St Louis, Missouri 63110; Faculties of Life Sciences and Medical and Human Sciences (A.W.), University of Manchester, Manchester M13 9PL, United Kingdom; and Department of Neurology (T.K., B.P.L., R.J.B), Washington University School of Medicine, St Louis, Missouri 63110.
Abstract
CONTEXT: In order to characterize diurnal changes in central leptin and its target neuropeptide, proopiomelanocortin (POMC), we measured leptin and POMC in cerebrospinal fluid (CSF) as related to changes in plasma leptin and soluble leptin receptor (sOB-R) levels. CSF and plasma levels of 20 amino acids (AA) were also measured because AA can affect brain POMC. DESIGN AND PARTICIPANTS: Stored CSF and plasma samples obtained from eight healthy subjects who served as controls for a previous study were evaluated. CSF was collected hourly over 33 h via indwelling subarachnoid catheter. Leptin, sOB-R, and POMC were measured by sensitive ELISA and AA by gas chromatography-mass spectrometry. RESULTS: There was a diurnal rhythm for plasma leptin with a peak at 2200 h (144% of baseline) and there was a similar diurnal rhythm for CSF leptin with a peak (117%) 3-5 h after the plasma peak. Plasma sOB-R was lowest at 0300 h and correlated negatively with plasma and CSF leptin. A diurnal rhythm for POMC in CSF was also detected with a peak (125%) at 0100 h. A positive correlation existed between CSF POMC and leptin in individual subjects over time. CSF levels of many AA increased at night. There was a significant correlation between CSF POMC and 10 AA, including leucine, isoleucine, tryptophan, and tyrosine. CONCLUSIONS: Diurnal changes occur in leptin and POMC in human CSF that likely reflect changes in central leptin and melanocortin activity. Our results suggest that nocturnal elevations in leptin, AA, and POMC may help to suppress appetite and feeding at night.
CONTEXT: In order to characterize diurnal changes in central leptin and its target neuropeptide, proopiomelanocortin (POMC), we measured leptin and POMC in cerebrospinal fluid (CSF) as related to changes in plasma leptin and soluble leptin receptor (sOB-R) levels. CSF and plasma levels of 20 amino acids (AA) were also measured because AA can affect brain POMC. DESIGN AND PARTICIPANTS: Stored CSF and plasma samples obtained from eight healthy subjects who served as controls for a previous study were evaluated. CSF was collected hourly over 33 h via indwelling subarachnoid catheter. Leptin, sOB-R, and POMC were measured by sensitive ELISA and AA by gas chromatography-mass spectrometry. RESULTS: There was a diurnal rhythm for plasma leptin with a peak at 2200 h (144% of baseline) and there was a similar diurnal rhythm for CSF leptin with a peak (117%) 3-5 h after the plasma peak. Plasma sOB-R was lowest at 0300 h and correlated negatively with plasma and CSF leptin. A diurnal rhythm for POMC in CSF was also detected with a peak (125%) at 0100 h. A positive correlation existed between CSF POMC and leptin in individual subjects over time. CSF levels of many AA increased at night. There was a significant correlation between CSF POMC and 10 AA, including leucine, isoleucine, tryptophan, and tyrosine. CONCLUSIONS: Diurnal changes occur in leptin and POMC in human CSF that likely reflect changes in central leptin and melanocortin activity. Our results suggest that nocturnal elevations in leptin, AA, and POMC may help to suppress appetite and feeding at night.
Authors: Randall J Bateman; Ling Y Munsell; John C Morris; Robert Swarm; Kevin E Yarasheski; David M Holtzman Journal: Nat Med Date: 2006-06-25 Impact factor: 53.440
Authors: Daniela Cota; Karine Proulx; Kathi A Blake Smith; Sara C Kozma; George Thomas; Stephen C Woods; Randy J Seeley Journal: Science Date: 2006-05-12 Impact factor: 47.728
Authors: Francois M H van Dielen; Cornelis van 't Veer; Wim A Buurman; Jan Willem M Greve Journal: J Clin Endocrinol Metab Date: 2002-04 Impact factor: 5.958
Authors: Yong Xu; Juli E Jones; Daisuke Kohno; Kevin W Williams; Charlotte E Lee; Michelle J Choi; Jason G Anderson; Lora K Heisler; Jeffrey M Zigman; Bradford B Lowell; Joel K Elmquist Journal: Neuron Date: 2008-11-26 Impact factor: 17.173
Authors: Alicia L Carreiro; Jaapna Dhillon; Susannah Gordon; Kelly A Higgins; Ashley G Jacobs; Breanna M McArthur; Benjamin W Redan; Rebecca L Rivera; Leigh R Schmidt; Richard D Mattes Journal: Annu Rev Nutr Date: 2016-07-17 Impact factor: 11.848
Authors: Gabrielle Page-Wilson; Kana Meece; Anne White; Michael Rosenbaum; Rudolph L Leibel; Richard Smiley; Sharon L Wardlaw Journal: Am J Physiol Endocrinol Metab Date: 2015-07-07 Impact factor: 4.310
Authors: Sunil K Panigrahi; Cristina D Toedesbusch; Jennifer S McLeland; Brendan P Lucey; Sharon L Wardlaw Journal: J Clin Endocrinol Metab Date: 2020-04-01 Impact factor: 5.958
Authors: Jenny-Marie T Wong; Paige A Malec; Omar S Mabrouk; Jennifer Ro; Monica Dus; Robert T Kennedy Journal: J Chromatogr A Date: 2016-04-04 Impact factor: 4.601
Authors: Peter Kirwan; Richard G Kay; Bas Brouwers; Vicente Herranz-Pérez; Magdalena Jura; Pierre Larraufie; Julie Jerber; Jason Pembroke; Theresa Bartels; Anne White; Fiona M Gribble; Frank Reimann; I Sadaf Farooqi; Stephen O'Rahilly; Florian T Merkle Journal: Mol Metab Date: 2018-08-21 Impact factor: 7.422